Vol.55 No.S-1 October 2007

In vitro antibacterial activity of garenoxacin

Masahiro Takahata, Yoshiko Fukuda, Naoko Futakuchi, Yoko Sugiura, Harumi Hisada, Shingo Mizunaga, Naoko Oogake, Yuko Ito, Yuko Shinmura, Masatoshi Nakatani, Tomoaki Tanaka, Takashi Komeno, Tomoko Kamiyama, Junichi Mitsuyama and Yozo Todo

Jpn. J. Chemother. 55 (S-1): 1-20, 2007

In vivo antibacterial activity of garenoxacin

Yoshiko Fukuda, Masahiro Takahata, Yoko Sugiura, Masatoshi Nakatani, Yuko Shinmura, Harumi Hisada, Takashi Komeno, Tomoko Kamiyama, Junichi Mitsuyama and Yozo Todo

Jpn. J. Chemother. 55 (S-1): 21-27, 2007

Single-dose toxicity studies of garenoxacin in mice, rats, and dogs

Shinichi Furubo, Takayuki Matsuno, Tsukasa Kozaki, Yoshitaka Yamamoto, Takahiro Sanzen and Yozo Todo

Jpn. J. Chemother. 55 (S-1): 28-33, 2007

Three-month repeated oral dose toxicity study of garenoxacin in rats

Mineko Nagasawa, Rie Fukui, Kazuo Kizawa, Nobuko Kito, Hiroyoshi Hayakawa, Takahiro Sanzen and Yozo Todo

Jpn. J. Chemother. 55 (S-1): 34-41, 2007

Three-month repeated oral dose toxicity study of garenoxacin in cynomolgus monkeys

Kazuo Kizawa, Hiroyuki Fukumoto, Takahiro Sanzen, Hideshi Tsusaki and Yozo Todo

Jpn. J. Chemother. 55 (S-1): 42-53, 2007

Genotoxicity study of garenoxacin

Teiichi Morita, Seiichi Mochizuki, Yasuyuki Nojima, Harumi Araki, Nobuko Kito, Madoka Nakajima, Takahiro Sanzen and Yozo Todo

Jpn. J. Chemother. 55 (S-1): 54-61, 2007

Reproductive and developmental toxicity studies of garenoxacin

Tsukasa Kozaki, Eiko Furubo, Takahiro Sanzen, Masatoshi Furukawa and Yozo Todo

Jpn. J. Chemother. 55 (S-1): 62-74, 2007

Phototoxicity study of garenoxacin in guinea pigs

Nobuko Kito, Masashi Kiyooka, Takahiro Sanzen and Yozo Todo

Jpn. J. Chemother. 55 (S-1): 75-77, 2007

Pharmacokinetics of garenoxacin in laboratory animal species

Hiroshi Kato, Hiroyoshi Hayakawa, Yoko Fukushima, Takumi Kadota, Hiroyuki Fukumoto and Yozo Todo

Jpn. J. Chemother. 55 (S-1): 78-86, 2007

In vitro metabolism and the effect on human cytochrome P450s of garenoxacin

Tetsuro Nakamura, Chie Tobise, Hiroshi Kato, Masaki Katai, Hiroyoshi Hayakawa and Yozo Todo

Jpn. J. Chemother. 55 (S-1): 87-94, 2007

Phase 1 clinical studies of oral garenoxacin in healthy Japanese adult subjects

Eiji Uchida

Jpn. J. Chemother. 55 (S-1): 95-115, 2007

Clinical phase II study of garenoxacin in patients with respiratory tract infections -openlabel, multicenter, noncomparative-

Hiroyuki Kobayashi, Akira Watanabe, Nobuki Aoki, Shigeki Odagiri, Yasuyuki Sano and Atsushi Saito

Jpn. J. Chemother. 55 (S-1): 116-126, 2007

Clinical phase III comparative study on garenoxacin versus levofloxacin in patients with bacterial pneumonia

Hiroyuki Kobayashi, Akira Watanabe, Nobuki Aoki, Shigeki Odagiri, Shin Kawai, Yoshihito Niki, Shigeru Kohno and Atsushi Saito

Jpn. J. Chemother. 55 (S-1): 127-143, 2007

Phase III study of garenoxacin in patients with secondary infection of chronic respiratory diseases

Hiroyuki Kobayashi, Yusuke Tanigawara, Akira Watanabe, Nobuki Aoki, Yasuyuki Sano, Shigeki Odagiri, Yoshihito Niki, Shigeru Kohno and Atsushi Saito

Jpn. J. Chemother. 55 (S-1): 144-161, 2007

Penetration into sputum study of garenoxacin in patients with secondary infection of chronic respiratory disease

Akira Watanabe, Katsunao Niitsuma, Hiroaki Takeda and Nobuki Aoki

Jpn. J. Chemother. 55 (S-1): 162-168, 2007

Clinical phase III study of oral garenoxacin in patients with community-acquired acute respiratory infection

Hiroyuki Kobayashi, Akira Watanabe, Nobuki Aoki, Shigeki Odagiri, Shin Kawai, Yoshihito Niki, Shigeru Kohno and Atsushi Saito

Jpn. J. Chemother. 55 (S-1): 169-184, 2007

Clinical phase III open-labeled study of oral garenoxacin in patients with respiratory tract infection by penicillin-resistant Streptococcus pneumoniae

Shigeru Kohno, Akira Watanabe, Nobuki Aoki, Kazuhiro Tateda, Hiroyuki Taniguchi, Yoshihito Niki and Yasunobu Hirata

Jpn. J. Chemother. 55 (S-1): 185-193, 2007

Clinical phase III open-label study of oral Garenoxacin in patients with otorhinolaryngological infection

Shunkichi Baba, Kenji Suzuki, Noboru Yamanaka and Koji Yajin

Jpn. J. Chemother. 55 (S-1): 194-205, 2007

Concomitant administration study of garenoxacin and theophylline

Yoshihito Niki and Koichiro Yoshida

Jpn. J. Chemother. 55 (S-1): 206-213, 2007

Relationship between oral administration of garenoxacin and QT interval

Yuji Murakawa

Jpn. J. Chemother. 55 (S-1): 214-221, 2007

Clinical response of garenoxacin against respiratory tract infection and otorhinolaryngological infection caused by multidrug-resistant Streptococcus pneumoniae

Shigeru Kohno, Hiroyuki Kobayashi, Shunkichi Baba and Masahiro Takahata

Jpn. J. Chemother. 55 (S-1): 222-230, 2007